Results 211 to 220 of about 293,399 (308)

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Mechanical gating of tendon fibrogenic transcription in systemic sclerosis. [PDF]

Nat Commun
Hussien AA, Knell R, Wunderli SL, Aronoff MR, Niederoest B, Renoux F, Hukara A, Foolen J, Wennemers H, Distler O, Snedeker JG.   +10 more
europepmc   +1 more source

Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

BMEMat, EarlyView.
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou, Jia Liu, Shulin Lai, Suhan Yin, Bingmin Luo, Longquan Shao, Yiyuan Kang   +6 more
wiley   +1 more source

Predictor factors of successful treatment response in interstitial lung disease-related systemic sclerosis. [PDF]

J Scleroderma Relat Disord
Danasasmita GW, Wibowo SAK, Rumende CM, Rizka A, Sumariyono S, Ariane A, Shatri H, Singh G.   +7 more
europepmc   +1 more source

Progressive Systemic Sclerosis

International Journal of Clinical Practice, 1964
openaire   +2 more sources

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Neutrophil reprogramming underlie vasculopathy and lung disease in systemic sclerosis. [PDF]

Cell Death Dis
Maugeri N, Ramirez GA, Capobianco A, Monno A, Arosio E, D'Ercole M, Bianchi ME, Rovere-Querini P, Iannone F, Matucci-Cerinic M, Manfredi AA.   +10 more
europepmc   +1 more source

Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]

, 2008
Jimenez, Sergio A., Rosenbloom, Joel
core   +1 more source

A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders

Clinical Pharmacology &Therapeutics, EarlyView.
Parkinsonian disorders, including Parkinson's disease, Lewy body dementia, multiple system atrophy, and progressive supranuclear palsy, are progressive neurodegenerative conditions with no treatment options to slow disease progression. This systematic review provides an overview of evidence of disease‐modifying therapies that have been evaluated in ...
Pepijn P.N.M. Eijsvogel, Lars M.G. Smits, Philip H.C. Kremer, Geert Jan Groeneveld   +3 more
wiley   +1 more source

Right Ventricular Strain and RV-Pulmonary Artery Coupling in Systemic Sclerosis: A Systematic Review. [PDF]

J Clin Med
Cealera E, Gurzun MM, Gache AC, Marc MS, Parepa IR, Dantes E.   +5 more
europepmc   +1 more source